Protease inhibitor regimen (once-daily vs twice-daily)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Protease inhibitor regimen (once-daily vs twice-daily), covering 2009-09-02 to 2009-09-02. Get the full timeline:
Most recent: Clinical Trial Update: HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults [Phase 3]